Navigation Links
Neurocrine Biosciences Reports Fourth Quarter And Year End 2012 Results
Date:2/8/2013

,946

56,347 

 

 NEUROCRINE BIOSCIENCES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands) (unaudited) December 31,2012December 31,2011Cash, cash equivalents and short-term marketable securities

$
73,013

$
29,103Other current assets

16,251

3,373Total current assets

189,264

132,476Property and equipment, net

1,900

1,586Long-term investments

480

—Restricted cash

4,335

4,306Total assets

$
95,979

$
38,368Current liabilities

$
5,646

$
47,110Long-term liabilities

25,961

31,177Stockholders' equity

154,372

60,081Total liabilities and stockholders' equity

$
95,979

$
38,368
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
2. Neurocrine Biosciences Reports Third Quarter 2012 Results
3. Neurocrine Biosciences Reports Second Quarter 2012 Results
4. Neurocrine Biosciences to Present at The 24th Annual Roth Conference
5. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
6. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
7. Sangamo BioSciences Announces Fourth Quarter And Full Year 2012 Conference Call And Webcast
8. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
11. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Working in collaboration with the National Amyloidosis Centre at ... Richmond Pharmacology is the first centre worldwide to dose a ... RNAi therapeutic being developed for the treatment of transthyretin-mediated amyloidosis ... Read press release ClinicalTrials.gov ... University of London , Richmond Pharmacology is ...
(Date:3/27/2015)... March 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a commercial focus on China , ... months ended December 31, 2014.  The ... ($0.05) per share, for the three months ended December ...
(Date:3/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... advanced testing solutions for the detection of foodborne ... three months and full year ended December 31, ... for the quarter ended December 31, 2014 was ... quarter of 2013 and $1.5 million for the ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... dealing with certain matters, including the appointment of auditors, ... March 26, 2015 (the "Meeting") was adjourned, as previously ... at 11:00 a.m. ( Toronto time). ... from that previous disclosed. The Meeting will reconvene at ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... ATLANTA, Sept. 29, 2011 GeoVax Labs, Inc. (OTCQB/OTCBB: ... and fight Human Immunodeficiency Virus (HIV) infections, announces that ... to receive academic honors on September 26 and October ... Officer Harriet L. Robinson, PhD, was honored as a ...
... as a symbol of long-lasting love. But semiconductor makers ... of long-lasting micromachines if a new method developed at ... carving these tough, capable crystals proves its worth.* The ... in a diamond surface, yielding potential benefits in both ...
... PLC (AIM: GTL) today conducted its annual meeting in London, ... Henderson, the non-executive chairman of the U.S. based bio-refining company, ... "GTL is pleased to report that margins ... period ending September 30, 2011 closely tracked the seasonal margins ...
Cached Biology Technology:GeoVax Labs' CSO and Chairman Receive Academic Honors 2GeoVax Labs' CSO and Chairman Receive Academic Honors 3NIST polishes method for creating tiny diamond machines 2
(Date:3/11/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ... Control Market by Product, Application & By Geography - ... their offering. , This report predicts that ... billion by 2020, with an estimated CAGR of 10.6%. ... products types such as contact cards & readers, contactless ...
(Date:3/10/2015)... March 10, 2015  Continuing its 167-year history of ... Schlemmer introduces The Eye Scanning Password Authenticator , ... access to secure websites or sensitive data. ... at international borders, the device has a small camera ... of the iris, converting them into an encrypted ID ...
(Date:3/10/2015)... --  Tute Genomics , pioneer in affordable, accurate and ... company PrimBio Research Institute to be its ... interpretation. PrimBio, a certified Life Technologies Ampliseq ... to support the work of experts on the front ... of exome sequencing services: 1) Targeted Exome and 2) ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... Chinese on EurekAlert! Chinese . , ... Rights and Resources Initiative (RRI) shows that despite more understanding, ... marginalized and ignored or exploited in resource management processes throughout ... reduction goals. This suite of analyses, released today ...
... program that trains emergency medical service technicians (EMS) to read ... and expedite treatment for the severe heart condition known as ... attack, has excellent results and should become the standard of ... of the Canadian Journal of Cardiology . ...
... thousands of small divots. Hit these cells with drugs and ... cancer drug. But a review published this week in the ... these 2D models in fact offer very little information about ... give researchers misleading results. "Up until the 1980s ...
Cached Biology News:Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized 2Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized 3Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized 4Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized 5Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized 6ECGs administered by paramedics can speed treatment for severe heart attacks 2ECGs administered by paramedics can speed treatment for severe heart attacks 33-D tumor models improve drug discovery success rate 23-D tumor models improve drug discovery success rate 3
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... XT is undoubtedly the most complete and ... concept of layers and subsets makes it ... for different data outputs, for example Cy3 ... as well as different subsets of genes ...
...
...
Biology Products: